None of us liked what has seemed like a toxic financing with the R&R deal. During the last AGM presentation, Thomas Mika said (paraphrased) that POET will not do another financing like the last one and he mentioned the term "non-dilutive" for the future.

Generally, I don't like penny promotional financing companies with questionable marketing strategies that seem to leave the retailer out. I hope that our next financing or two will be non-dilutive / accreditive ones with industry-related corporate partner(s) that can accelerate POET to the next level. Hopefully, our revenue growth will prevent us of having to go down that road again; but I remain open to quality partner financings that raise the sustained value of our share price and add solid market cap and respect for our stock.

POET management must assure us that they will not ever go down a toxic road with such a lousy financing like the last one that decimated our share price. Since our BOD (David L., in particular, said (paraphrased) that it is relatively easy to achieve $50 million in sales) --- our target revenue for 2019 --- then we should not really ever have to do a financing like the last one with R&R; especially, when those sales are at high margin. 

Monolithic